Specialty and surplus lines insurer Ironshore Inc. is once more on the course to be a publicly traded company after it filed for an initial public offering on July 22.
This move comes two years after the company previously filed for an IPO with the U.S. Securities and Exchange Commission. but those plans were put on hold after Chinese conglomerate Fosun International Ltd. bought a stake in the Hamilton, Bermuda-based insurer. Fosun, which paid $1.8 billion for the remaining 80% share in Ironshore that it did not already own in May 2015, will receive all the proceeds from the offering.
In a filing on July 23, Ironshore said that the proposed offering price would be $100 million. It was noted, however, that this figure was “estimated solely for the purpose of computing the amount of the registration fee” required for the filing.
According to the filing, Ironshore reported gross written premiums of $2.16 billion in 2015. About 65% of its business is generated from the United States.
Full Content: Business Insurance
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas